| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 1. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | lidocaine/tetracaine (Rapydan®) |
| Formulation | 70 mg/70 mg medicated plaster |
| Reference number | 186 |
| Indication | Surface anaesthesia of the skin in connection with needle puncture on normal intact skin in children from 3 years of age |
| Company | EUSA Pharma (Europe) Ltd |
| BNF chapter | Anaesthesia |
| Assessment type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 02/01/2008 |